Diphenylmethylpiperazine
Appearance
| Names | |
|---|---|
| Preferred IUPAC name
1-(Diphenylmethyl)piperazine | |
| Other names
1-benzhydrylpiperazine; Norcyclizine
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.011.516 |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C17H20N2 | |
| Molar mass | 252.35 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Diphenylmethylpiperazine, also known as benzhydrylpiperazine, is a chemical compound and piperazine derivative. It features a piperazine ring with a benzhydryl (diphenylmethyl) group bound to one of the nitrogens.[1][2] Cyclizine, an antihistamine and anticholinergic drug used to treat motion sickness, is the methylated derivative of diphenylmethylpiperazine, and the antihistamine cinnarizine is another derivative. 1-Benzhydrylpiperazine has been described as having "amphetamine-like effects".[3]
References
[edit]- ^ Calderon SN (2011). "Nonpeptidic delta (delta) opioid agonists and antagonists of the diarylmethylpiperazine class: what have we learned?". Top Curr Chem. 299: 121–140. PMID 21630509.
- ^ Kaczor A, Matosiuk D (2002). "Non-peptide opioid receptor ligands - recent advances. Part I - agonists". Curr Med Chem. 9 (17): 1567–1589. PMID 12171553.
- ^ Arslan Z, et al. 1-Benzhydryl-piperazine: Isolation, structure determination, and in silico studies for a novel potential narcotic agent detected in sports supplements. Journal of Food Composition and Analysis 2024; 135: 106682. doi:10.1016/j.jfca.2024.106682

